MicroPort Scientific Corp.

Company Overview

MicroPort Scientific Corp. is a diversified global medical technology company that manufactures and markets a broad range of medical devices and solutions across multiple therapeutic areas, including interventional cardiology, orthopedics, neurovascular and endovascular interventions, cardiac rhythm management, surgical robotics, and critical care. Its products serve healthcare providers and patients in more than 90 countries, reflecting a commitment to innovation and improving clinical outcomes worldwide.

MicroPort Scientific’s surgical robotics segment, primarily through Shanghai MicroPort MedBot (Group) Co. Ltd., a subsidiary of MicroPort Scientific Corp., has developed robotic-assisted systems for orthopedic surgery. One such system is the SkyWalker (also referred to as Honghu) orthopedic surgical robot, which has received regulatory clearances, including CE marking in the European Union, U.S. FDA clearance, and approvals in other markets. The SkyWalker system is designed to support procedures such as total knee and hip arthroplasty by providing robotic guidance based on preoperative imaging and intraoperative navigation to support surgical accuracy.

Financial Highlights (FY 2025)

Company's Business Segments

• Cardiovascular Devices Business : The cardiovascular devices business offers integrated solutions for the treatment of coronary artery-related diseases, and develops, manufactures and commercializes coronary stents and related delivery systems, along with balloon catheters, passive accessories, active devices and other products
• Orthopedics Devices Business : The orthopedics devices business offers overall solutions for the treatment of orthopedic problems, with an extensive range of orthopedics products that include reconstructive joints, spine and trauma products, and other professional implants and instruments.
• CRM Business : This segment is principally engaged in developing, manufacturing and marketing products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, with products covering pacemakers, defibrillators, cardiac resynchronization therapy devices and supporting portfolio of monitoring products used in combination.
• Endovascular and Peripheral Vascular Devices Business : The endovascular and peripheral vascular devices business focuses on providing integrated disease solutions for the interventional treatment of abdominal and thoracic aortic aneurysms, peripheral vascular diseases, aortic dissection aneurysms and other arteriovenous related diseases.
• Neurovascular Devices Business : The neurovascular devices business provides solutions for the treatment of cerebrovascular diseases, including hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke, and in the R&D, production and commercialization of neurovascular therapeutic and access devices.
• Heart Valve Business : This business segment includes four certified products: VitaFlow Transcatheter Aortic Valve Implantation and Delivery System , VitaFlow Liberty Transcatheter Aortic Valve Implantation and Retrievable Delivery System (including the procedural accessory products as their offerings), Alwide Plus Balloon Catheter and AccuSniper Double-Layer Balloon Catheter, and various transcatheter aortic valve implantation products, transcatheter mitral valve products, transcatheter tricuspid valve products and procedural accessory products at different development stages.
• Surgical Robot Business : The surgical robot business is dedicated to providing robotic intelligent surgical total solutions and development needs of minimally invasive surgeries.
• Surgical Devices Business : The MOBYBOX system.